InspireMD (NSPR) Competitors $2.42 -0.02 (-0.86%) As of 09:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NSPR vs. RXST, DCTH, DRTS, CARL, NPCE, TCMD, SNWV, BWAY, SMTI, and SIShould you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include RxSight (RXST), Delcath Systems (DCTH), Alpha Tau Medical (DRTS), Carlsmed (CARL), NeuroPace (NPCE), Tactile Systems Technology (TCMD), Sanuwave Health (SNWV), Brainsway (BWAY), Sanara MedTech (SMTI), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry. InspireMD vs. Its Competitors RxSight Delcath Systems Alpha Tau Medical Carlsmed NeuroPace Tactile Systems Technology Sanuwave Health Brainsway Sanara MedTech Shoulder Innovations RxSight (NASDAQ:RXST) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations. Does the media refer more to RXST or NSPR? In the previous week, RxSight had 2 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for RxSight and 1 mentions for InspireMD. RxSight's average media sentiment score of 0.00 equaled InspireMD'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InspireMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, RXST or NSPR? InspireMD has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$147.06M2.29-$27.45M-$0.80-10.30InspireMD$7.07M14.28-$19.92M-$0.83-2.91 Is RXST or NSPR more profitable? RxSight has a net margin of -21.93% compared to InspireMD's net margin of -413.96%. RxSight's return on equity of -11.56% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-21.93% -11.56% -10.31% InspireMD -413.96%-69.42%-57.68% Do analysts rate RXST or NSPR? RxSight currently has a consensus target price of $10.00, indicating a potential upside of 21.34%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 86.03%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than RxSight.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 3 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.85InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, RXST or NSPR? RxSight has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Do institutionals & insiders have more ownership in RXST or NSPR? 78.8% of RxSight shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 9.6% of RxSight shares are owned by company insiders. Comparatively, 34.1% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryRxSight beats InspireMD on 8 of the 15 factors compared between the two stocks. Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSPR vs. The Competition Export to ExcelMetricInspireMDSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$100.92M$68.01M$6.13B$22.02BDividend YieldN/AN/A5.69%3.58%P/E Ratio-3.2310.4785.8629.86Price / Sales14.2833.04540.5364.35Price / CashN/A18.4137.9224.43Price / Book1.3214.5812.984.64Net Income-$19.92M-$26.69M$3.30B$1.01B7 Day Performance0.37%-0.02%4.73%0.44%1 Month Performance-1.67%-0.22%9.96%3.13%1 Year Performance-8.02%50.20%84.61%15.30% InspireMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPRInspireMD2.9965 of 5 stars$2.42-0.9%$4.50+86.0%-9.3%$100.92M$7.07M-3.2350News CoverageRXSTRxSight2.3037 of 5 stars$9.27-1.2%$10.00+7.9%-83.3%$380.97M$139.93M-11.64220Analyst ForecastDCTHDelcath Systems2.6425 of 5 stars$10.75-1.4%$24.50+127.9%+31.5%$375.90M$37.21M214.9260Positive NewsAnalyst ForecastDRTSAlpha Tau Medical1.9648 of 5 stars$4.32+1.6%$9.00+108.3%+82.9%$366.85MN/A-9.0180News CoverageAnalyst ForecastCARLCarlsmedN/A$13.25-1.5%N/AN/A$352.20M$38.27M0.00100Gap DownNPCENeuroPace3.8221 of 5 stars$10.32+0.8%$16.60+60.8%+73.4%$342.51M$79.91M-12.33170News CoveragePositive NewsAnalyst ForecastTCMDTactile Systems Technology3.5452 of 5 stars$13.88+0.4%$13.50-2.8%+5.5%$310.12M$292.98M22.441,037Analyst ForecastSNWVSanuwave Health3.0908 of 5 stars$34.41-0.5%$55.00+59.8%N/A$294.83M$39.19M-4.1740Trending NewsAnalyst ForecastAnalyst RevisionBWAYBrainsway2.8063 of 5 stars$15.290.0%$18.00+17.8%+64.1%$289.96M$41.02M58.79120SMTISanara MedTech1.9212 of 5 stars$31.73-0.4%$50.00+57.6%+4.4%$283.24M$86.67M-27.4460News CoverageAnalyst ForecastGap UpSIShoulder Innovations2.8066 of 5 stars$12.66+0.8%$19.60+54.9%N/A$258.88MN/A-0.4261Gap Down Related Companies and Tools Related Companies RXST Competitors DCTH Competitors DRTS Competitors CARL Competitors NPCE Competitors TCMD Competitors SNWV Competitors BWAY Competitors SMTI Competitors SI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSPR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
